HK1003114A1 - FLuorocytidine derivatives their preparation and medical preparations containing them - Google Patents

FLuorocytidine derivatives their preparation and medical preparations containing them

Info

Publication number
HK1003114A1
HK1003114A1 HK98102225A HK98102225A HK1003114A1 HK 1003114 A1 HK1003114 A1 HK 1003114A1 HK 98102225 A HK98102225 A HK 98102225A HK 98102225 A HK98102225 A HK 98102225A HK 1003114 A1 HK1003114 A1 HK 1003114A1
Authority
HK
Hong Kong
Prior art keywords
preparation
preparations containing
medical preparations
fluorocytidine derivatives
fluorocytidine
Prior art date
Application number
HK98102225A
Other languages
English (en)
Inventor
Morio Fujiu
Masanori Ishitsuka
Isao Umeda
Kazuteru Yokose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1003114A1 publication Critical patent/HK1003114A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
HK98102225A 1987-11-17 1998-03-17 FLuorocytidine derivatives their preparation and medical preparations containing them HK1003114A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87116926 1987-11-17

Publications (1)

Publication Number Publication Date
HK1003114A1 true HK1003114A1 (en) 1998-10-09

Family

ID=8197450

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102225A HK1003114A1 (en) 1987-11-17 1998-03-17 FLuorocytidine derivatives their preparation and medical preparations containing them

Country Status (35)

Country Link
US (1) US4966891A (fi)
EP (1) EP0316704B1 (fi)
JP (1) JPH0678350B2 (fi)
KR (1) KR970000241B1 (fi)
CN (1) CN1022688C (fi)
AR (1) AR247217A1 (fi)
AT (1) ATE124951T1 (fi)
AU (1) AU619220B2 (fi)
CA (1) CA1327358C (fi)
CS (1) CS274486B2 (fi)
DE (2) DE3854148D1 (fi)
DK (1) DK170893B1 (fi)
DZ (1) DZ1270A1 (fi)
ES (1) ES2074429T3 (fi)
FI (1) FI89804C (fi)
GR (1) GR3017686T3 (fi)
HK (1) HK1003114A1 (fi)
HU (1) HU199866B (fi)
IE (1) IE883430L (fi)
IL (1) IL88363A0 (fi)
IS (1) IS1895B (fi)
LT (1) LT2185B (fi)
LU (1) LU90769I2 (fi)
LV (1) LV5624A3 (fi)
MC (1) MC1992A1 (fi)
MX (1) MX173347B (fi)
NL (1) NL300045I2 (fi)
NO (2) NO171167C (fi)
NZ (1) NZ226923A (fi)
PH (1) PH25641A (fi)
PT (1) PT89009B (fi)
SU (1) SU1736342A3 (fi)
UA (1) UA19333A (fi)
YU (1) YU47122B (fi)
ZA (1) ZA888428B (fi)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258360B1 (en) * 1989-05-04 2001-07-10 Igen International, Inc. Prodrugs activated by targeted catalytic proteins
US5527782A (en) * 1990-03-13 1996-06-18 Acic (Canada) Inc. 5-halo-2,3'-O-cyclocytidines
AU671491B2 (en) 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
TW254946B (fi) * 1992-12-18 1995-08-21 Hoffmann La Roche
US5476932A (en) * 1994-08-26 1995-12-19 Hoffmann-La Roche Inc. Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20010051348A1 (en) * 2000-01-28 2001-12-13 Lee Chee Wee Novel ligands and methods for preparing same
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US6774758B2 (en) * 2002-09-11 2004-08-10 Kalyan P. Gokhale Low harmonic rectifier circuit
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
EP1631278A4 (en) * 2003-05-20 2006-09-20 Aronex Pharmaceuticals Inc COMBINED CHEMOTHERAPY COMPRISING CAPECITABINE AND A COMPLEX BASED ON LIPOSOMIC PLATINUM
DK1706414T3 (da) * 2003-12-22 2008-10-13 Hoffmann La Roche Fremgangsmåde til fluorcytidinderivater
BRPI0507734A (pt) * 2004-02-18 2007-07-10 Astrazeneca Ab composto ou um sal, pró-droga ou solvato do mesmo, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
ES2322709T3 (es) * 2004-02-18 2009-06-25 Astrazeneca Ab Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4－氧羰基胞嘧啶衍生物及制备方法与应用
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
KR101061850B1 (ko) 2004-09-08 2011-09-02 삼성전자주식회사 박막 트랜지스터 표시판 및 그 제조방법
GB0421294D0 (en) * 2004-09-24 2004-10-27 Angiogene Pharm Ltd Bioreductively-activated prodrugs
BRPI0516595A (pt) 2004-10-16 2008-09-23 Astrazeneca Ab processo para fabricar um composto, e, composto
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
CN113975393A (zh) 2005-02-03 2022-01-28 综合医院公司 治疗吉非替尼耐药性癌症的方法
NO322682B1 (no) * 2005-03-18 2006-11-27 Clavis Pharma Asa Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
EP1868608A2 (en) * 2005-04-01 2007-12-26 F. Hoffmann-Roche AG Method for administration of capecitabine
JP2008542247A (ja) * 2005-05-24 2008-11-27 アストラゼネカ アクチボラグ グルコキナーゼモジュレーターとしての２−フェニル置換イミダゾール［４，５ｂ］ピリジン／ピラジンおよびプリン誘導体
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
EP1910350A1 (en) * 2005-07-09 2008-04-16 AstraZeneca AB 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
EP2027113A1 (en) * 2005-07-09 2009-02-25 AstraZeneca AB Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
CN100569790C (zh) * 2005-07-15 2009-12-16 上海奥锐特国际贸易有限公司 合成n4-酰基-5＇-脱氧-5-氟胞苷衍生物的方法
AU2006272343B2 (en) * 2005-07-21 2012-09-13 Nuvo Research Ag Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment.
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
US20070104721A1 (en) 2005-11-04 2007-05-10 Wyeth Antineoplastic combinations with mTOR inhibitor,herceptin, and/or hki-272
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
CN100425617C (zh) * 2006-10-31 2008-10-15 浙江海正药业股份有限公司 一种含氟嘧啶类化合物烷氧羰酰化的方法
CA2671535A1 (en) 2006-12-21 2008-06-26 Astrazeneca Ab Novel crystalline compound useful as glk activator
ITMI20070435A1 (it) 2007-03-05 2008-09-06 Innovate Biotechnology Srl 2',3'-di-o-acil-5-fluoronucleosidi
WO2008131062A2 (en) * 2007-04-20 2008-10-30 Dr. Reddy's Laboratories Ltd. Process for preparing capecitabine
EP2164856A1 (en) * 2007-06-01 2010-03-24 Synthon B.V. Processes related to making capecitabine
WO2009042064A2 (en) 2007-09-21 2009-04-02 Nektar Therapeutics Al, Corporation Oligomer-nucleoside phosphate conjugates
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
EP2225566A1 (en) * 2008-01-03 2010-09-08 Plus Chemicals S.A. Process for the preparation of capecitabine
WO2010008744A2 (en) 2008-06-17 2010-01-21 Wyeth Antineoplastic combinations containing hki-272 and vinorelbine
KR20110052676A (ko) 2008-08-04 2011-05-18 아스트라제네카 아베 피라졸로[3,4]피리미딘-4-일 유도체 및 당뇨병 및 비만을 치료하기 위한 이의 용도
MX2011001318A (es) 2008-08-04 2011-03-04 Wyeth Llc Combinaciones antineoplasicas de 4-anilino-3-cianoquinolinas y capecitabina.
WO2010065586A2 (en) * 2008-12-02 2010-06-10 Dr. Reddy's Laboratories Ltd. Preparation of capecitabine
WO2010063080A1 (en) * 2008-12-05 2010-06-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
CN101787066B (zh) * 2009-01-23 2013-07-31 高峰 阿糖胞苷衍生物及其在抗癌抗肿瘤中的用途
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
RU2011139363A (ru) 2009-04-06 2013-05-20 ВАЙЕТ ЭлЭлСи Схема лечения рака молочной железы с использованием нератиниба
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
CN101875680B (zh) * 2009-04-28 2012-07-25 上海信旗医药科技有限公司 一种核苷类化合物及其制备方法和应用
US20110021769A1 (en) * 2009-07-23 2011-01-27 Scinopharm Taiwan Ltd. Process for Producing Fluorocytidine Derivatives
SI2835053T1 (sl) 2010-03-12 2016-09-30 Genzyme Corporation Kombinirana terapija za zdravljenje raka dojke
CN108949772A (zh) 2012-04-02 2018-12-07 现代泰克斯公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
CA2868996A1 (en) 2012-04-02 2013-10-10 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
UA119229C2 (uk) 2012-09-26 2019-05-27 Ф. Хоффманн-Ля Рош Аг Циклічні ефіри піразол-4-ілгетероциклілкарбоксамідних сполук та способи їх застосування
US9447137B2 (en) 2012-11-07 2016-09-20 Nucorion Pharmaceuticals, Inc. Substituted gemcitabine aryl amide analogs
US10138507B2 (en) 2013-03-15 2018-11-27 Modernatx, Inc. Manufacturing methods for production of RNA transcripts
US10000521B2 (en) 2013-03-15 2018-06-19 Nucorion Pharmaceuticals, Inc. Substituted gemcitabine bicyclic amide analogs and treatment methods using same
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
CA2923029A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
CN103450301B (zh) * 2013-09-09 2015-09-09 南通大学 法尼基硫代水杨酸-核苷缀合物、其制备方法及其医药用途
JP2016538829A (ja) 2013-10-03 2016-12-15 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 低密度リポタンパク質受容体をコードするポリヌクレオチド
WO2018002739A1 (en) * 2016-06-28 2018-01-04 Cellix Bio Private Limited Compositions and methods for the treatment of cancer
ES2914123T3 (es) 2017-01-09 2022-06-07 Shuttle Pharmaceuticals Inc Inhibidores selectivos de la histona desacetilasa para el tratamiento de una enfermedad humana
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
JP7173613B2 (ja) 2017-04-26 2022-11-16 カールマン，トーマス，アイ． 多標的ヌクレオシド誘導体
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
WO2019139921A1 (en) 2018-01-09 2019-07-18 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
CN111801339A (zh) * 2018-01-19 2020-10-20 纽科利制药公司 5-氟尿嘧啶化合物
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
WO2020026054A1 (en) * 2018-08-03 2020-02-06 Cellix Bio Private Limited Compositions and methods for the treatment of cancer
CN109651467A (zh) * 2019-01-15 2019-04-19 齐鲁天和惠世制药有限公司 一种卡培他滨杂质及其制备方法
EP4143199A1 (en) 2020-04-21 2023-03-08 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
WO2022020811A1 (en) 2020-07-24 2022-01-27 Strand Therapeutics, Inc. Lipidnanoparticle comprising modified nucleotides
KR20230129479A (ko) 2021-01-08 2023-09-08 스트랜드 세러퓨틱스 인코포레이티드 발현 구성체 및 이의 용도
WO2023212618A1 (en) 2022-04-26 2023-11-02 Strand Therapeutics Inc. Lipid nanoparticles comprising venezuelan equine encephalitis (vee) replicon and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404144A (en) * 1965-12-23 1968-10-01 Research Corp 1-beta-d-arabinofuranosyl-5-fluorocytosine compounds
GB1379410A (en) * 1971-06-08 1975-01-02 Upjohn Co 1-beta-d-arabino-furanosyl-n4-alpha-aminoacylcytosines
JPS52153977A (en) * 1976-06-11 1977-12-21 Daikin Ind Ltd Synthesis of 5-fluorouracil and its derivatives
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
CH633810A5 (en) * 1978-01-01 1982-12-31 Hoffmann La Roche Novel nucleosides and process for their preparation
FR2528311B1 (fr) * 1982-06-14 1985-06-14 Synthelabo Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
JPS61112093A (ja) * 1984-11-05 1986-05-30 Wakunaga Seiyaku Kk ヌクレオチド誘導体

Also Published As

Publication number Publication date
YU47122B (sh) 1994-12-28
NO171167C (no) 1993-02-03
DK170893B1 (da) 1996-03-04
SU1736342A3 (ru) 1992-05-23
PT89009A (pt) 1988-12-01
CN1033183A (zh) 1989-05-31
DE3854148D1 (de) 1995-08-17
LT2185B (lt) 1993-10-15
JPH01153696A (ja) 1989-06-15
JPH0678350B2 (ja) 1994-10-05
YU209188A (en) 1990-08-31
NO171167B (no) 1992-10-26
FI89804B (fi) 1993-08-13
IS1895B (is) 2003-10-20
DK640388A (da) 1989-05-18
DZ1270A1 (fr) 2004-09-13
NL300045I2 (nl) 2002-01-02
PT89009B (pt) 1993-02-26
CS274486B2 (en) 1991-04-11
CS747588A2 (en) 1990-09-12
HU199866B (en) 1990-03-28
CN1022688C (zh) 1993-11-10
UA19333A (uk) 1997-12-25
GR3017686T3 (en) 1996-01-31
FI885329A0 (fi) 1988-11-17
EP0316704A2 (de) 1989-05-24
MX173347B (es) 1994-01-03
KR890008162A (ko) 1989-07-10
FI885329A (fi) 1989-05-18
US4966891A (en) 1990-10-30
AU2516888A (en) 1989-05-25
AR247217A1 (es) 1994-11-30
NO2001013I2 (no) 2006-05-01
AU619220B2 (en) 1992-01-23
ZA888428B (en) 1989-06-28
NZ226923A (en) 1990-10-26
IE883430L (en) 1989-05-17
DE10199027I1 (de) 2001-08-02
EP0316704A3 (en) 1990-11-22
EP0316704B1 (de) 1995-07-12
HUT48267A (en) 1989-05-29
NO885106L (no) 1989-05-18
LV5624A3 (lv) 1994-05-10
MC1992A1 (fr) 1989-11-30
DK640388D0 (da) 1988-11-16
KR970000241B1 (ko) 1997-01-08
ES2074429T3 (es) 1995-09-16
DE10199027I2 (de) 2002-01-31
PH25641A (en) 1991-08-21
NO885106D0 (no) 1988-11-16
NL300045I1 (nl) 2001-08-01
CA1327358C (en) 1994-03-01
ATE124951T1 (de) 1995-07-15
IS3412A7 (is) 1989-05-18
LU90769I2 (fr) 2001-07-02
MX13836A (es) 1993-10-01
FI89804C (fi) 1993-11-25
IL88363A0 (en) 1989-06-30

Similar Documents

Publication Publication Date Title
HK1003114A1 (en) FLuorocytidine derivatives their preparation and medical preparations containing them
HU906229D0 (en) Medical preparations
GR860342B (en) 11b- phenyl-gonane their preparation and pharmaceutical preparations containing them
IL88182A0 (en) Derivatives of 1-desoxynojirimicyin and 1-desoxymannonojirimycin,their preparation and their use in medicaments
NZ215997A (en) Milbemycin derivatives and pesticidal compositions and preparations
HK14792A (en) Medicament adsorbates and their preparation
GR3003070T3 (en) Benzoxazole derivatives and preparation thereof
PH25104A (en) Acyl derivatives and pharmaceutical preparation thereof
IL90158A0 (en) Perfluoropolyether derivatives and their preparation
NZ225837A (en) Avermectin derivatives and pesticidal compositions
IL90690A0 (en) Tissue equivalents and their preparation
IL85529A (en) Biphenylalkenyl-substituted tetrazole derivatives and their preparation
IL88989A0 (en) 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them
ZA885150B (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
EP0142732A3 (en) Pheophorbide derivatives and pharmaceutical preparations containing them
IL88138A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL91356A0 (en) Therapeutic nucleosides,their preparation and pharmaceutical compositions containing them
NZ221350A (en) Uridine derivatives and pharmaceutical preparation
PH24960A (en) Acyl derivatives and pharmaceutical preparation thereof
EP0287471A3 (en) Carboxystyrene derivatives and drugs containing them as effective ingredients
IL86814A0 (en) Aminocyclopentyl ethers and their preparation and pharmaceutical formulation
NZ227594A (en) Human interleukin-1alpha and preparations thereof
IL87586A0 (en) 3'-demethoxyepipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
IL85738A0 (en) Nucleoside derivatives,their preparation and pharmaceutical compositions containing them
GB8719375D0 (en) Pharmaceutical preparations

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20081106